Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:1151-1159
Published online before print April 30, 2009, doi: 10.1161/CIRCRESAHA.108.191460
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/10/1151    most recent
CIRCRESAHA.108.191460v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kokai, E.
Right arrow Articles by Wirth, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kokai, E.
Right arrow Articles by Wirth, T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Related Collections
Right arrow Angiogenesis
Right arrow Apoptosis
(Circulation Research. 2009;104:1151.)
© 2009 American Heart Association, Inc.


Molecular Medicine

Myc Regulates Embryonic Vascular Permeability and Remodeling

Enikö Kokai, Florian Voss, Frank Fleischer, Sybille Kempe, Dragan Marinkovic, Hartwig Wolburg, Frank Leithäuser, Volker Schmidt, Urban Deutsch, Thomas Wirth

From the Institute of Physiological Chemistry (E.K., S.K., D.M., T.W.), Department of Pathology (F.L.), and Institute of Stochastics (F.V., F.F., V.S.), Ulm University, Germany; Institute of Pathology (H.W.), University of Tübingen Germany; and Theodor Kocher Institute (U.D.), University Bern, Switzerland.

Correspondence to Thomas Wirth, Physiological Chemistry, Albert-Einstein-Allee 11, Ulm 89081, Germany. E-mail thomas.wirth{at}uni-ulm.de

Previous work has shown that c-Myc is required for adequate vasculogenesis and angiogenesis. To further investigate the contribution of Myc to these processes, we conditionally expressed c-Myc in embryonic endothelial cells using a tetracycline-regulated system. Endothelial Myc overexpression resulted in severe defects in the embryonic vascular system. Myc-expressing embryos undergo widespread edema formation and multiple hemorrhagic lesions. They die between embryonic days 14.5 and 17.5. The changes in vascular permeability are not caused by deficiencies in vascular basement membrane composition or pericyte coverage. However, the overall turnover of endothelial cells is elevated as is revealed by increased levels of both proliferation and apoptosis. Whole-mount immunohistochemical analysis revealed alterations in the architecture of capillary networks. The dermal vasculature of Myc-expressing embryos is characterized by a reduction in vessel branching, which occurs despite upregulation of the proangiogenic factors vascular endothelial growth factor-A and angiopoietin-2. Thus, the net outcome of an excess of vascular endothelial growth factor-A and angiopoietin-2 in the face of an elevated cellular turnover appears to be a defect in vascular integrity.


Key Words: Myc • VEGF-A • vascular permeability • angiogenesis